Abstract
Giant cell tumors (GCTs) are generally benign, locally aggressive lesions mostly located in the metaphysis of long bones. GCTs of the skull are rare and the majority of the cases have been presented as case reports. The authors retrospectively reported 18 patients with GCTs of the skull at a single institution from April 1994 to February 2012 and summarized the clinical, radiological, pathological characteristics and management of the disease. Meanwhile, a systematic review of 94 case reports of GCTs of the skull was performed. Headache and symptoms related to the involvement of intracranial nerves were the most common symptoms. Over 90 % of the tumors originated from sphenoid and temporal bones. On MRI, very low signal on T2-weighted images were found highly indicative of GCTs of the temporal bone. Univariate analysis revealed that extent of tumor resection and post-operative radiation therapy (RT) were prognostic factors significantly influencing the survival of the patients. We concluded that complete tumor resection is the optimal goal in treating this disease and adjuvant RT should be given once tumor residual is inevitable.
Similar content being viewed by others
References
Epstein N, Whelan M, Reed D, Aleksic S (1982) Giant cell tumor of the skull: a report of two cases. Neurosurgery 11:263–267
Bertoni F, Unni KK, Beabout JW, Ebersold MJ (1992) Giant cell tumor of the skull. Cancer 70:1124–1132
Geissger JD, Siqueira EB, Ross ER (1970) Giant cell tumors of the sphenoid bone. J Neurosurg 32:665–670
Wolfe JR, Scheithauer BW, Dahlin DC (1983) Giant-cell tumor of the sphenoid bone. Review of 10 cases. J Neurosurg 59:322–327
Kinney SE, Sebek BA (1985) Rare tumors of the skull base and temporal bone. Am J Otol Suppl:135–142
Motomochi M, Handa Y, Makita Y, Hashi K (1985) Giant cell tumor of the skull. Surg Neurol 23:25–30
Findlay JM, Chiasson D, Hudson AR, Chui M (1987) Giant-cell tumor of the middle cranial fossa. Case report. J Neurosurg 66:924–928
Watkins LD, Uttley D, Archer DJ, Wilkins P, Plowman N (1992) Giant cell tumors of the sphenoid bone. Neurosurgery 30:576–581
Vernet O, Ducrey N, Deruaz JP, de Tribolet N (1993) Giant cell tumor of the orbit. Neurosurgery 32:848–851
do Amaral C, Julio GL, Cardoso LA, Bueno MA (1994) Craniofacial treatment of giant-cell tumors of the sphenoid bone. J Craniofac Surg 5:254–256
Rock JP, Mahmood A, Cramer HB (1994) Giant cell tumor of the skull base. Am J Otol 15:268–272
Silvers AR, Som PM, Brandwein M, Chong JL, Shah D (1996) The role of imaging in the diagnosis of giant cell tumor of the skull base. AJNR Am J Neuroradiol 17:1392–1395
Weber AL, Hug EB, Muenter MW, Curtin HD (1997) Giant-cell tumors of the sphenoid bone in four children: radiological, clinical, and pathological findings. Skull Base Surg 7:163–173
Kattner KA, Stroink A, Gupta K, Fukushima T, Li C (1998) Giant cell tumor of the sphenoid bone. Skull Base Surg 8:93–97
Yamamoto M, Fukushima T, Sakamoto S, Tomonaga M (1998) Giant cell tumor of the sphenoid bone: long-term follow-up of two cases after chemotherapy. Surg Neurol 49:547–552
Sheikh M, Chisti FA, Sinan T (1999) Giant cell tumour of the temporal bone: case report and review of the literature. Australas Radiol 43:113–115
Spallone A, Flores GL, Zaldivar LO, Estupinan B (1999) Giant cell tumor (osteoclastoma) of the petrous bone: case report. Skull Base Surg 9:155–159
Lee HJ, Lum C (1999) Giant-cell tumor of the skull base. Neuroradiology 41:305–307
Sharma RR, Mahapatra AK, Pawar SJ, Sousa J, Dev EJ (2002) Craniospinal giant cell tumors: clinicoradiological analysis in a series of 11 cases. J Clin Neurosci 9:41–50
Bibas-Bonet H, Fauze RA, Lavado MG, Paez RO, Nieman J (2003) Garcin syndrome resulting from a giant cell tumor of the skull base in a child. Pediatr Neurol 28:392–395
Chan J, Gannon FH, Thompson LD (2003) Malignant giant cell tumor of the sphenoid. Ann Diagn Pathol 7:100–105
Tang JY, Wang CK, Su YC, Yang SF, Huang MY, Huang CJ (2003) MRI appearance of giant cell tumor of the lateral skull base: a case report. Clin Imaging 27:27–30
Harris AE, Beckner ME, Barnes L, Kassam A, Horowitz M (2004) Giant cell tumor of the skull: a case report and review of the literature. Surg Neurol 61:274–277
Pai SB, Lalitha RM, Prasad K, Rao SG, Harish K (2005) Giant cell tumor of the temporal bone: a case report. BMC Ear Nose Throat Disord 5:8
Zorlu F, Selek U, Soylemezoglu F, Oge K (2006) Malignant giant cell tumor of the skull base originating from clivus and sphenoid bone. J Neurooncol 76:149–152
Wang Y, Honda K, Suzuki S, Ishikawa K (2006) Giant cell tumor at the lateral skull base. Am J Otolaryngol 27:64–67
Kashiwagi N, Hirabuki N, Andou K, Yoshifumi N, Tanaka H, Morino H, Taki T, Ishikura R, Hirota S, Onishi H, Nakamura H (2006) MRI and CT findings of the giant cell tumors of the skull; five cases and a review of the literature. Eur J Radiol 58:435–443
Elder JB, Berry C, Gonzalez-Gomez I, Kreger MD, McComb JG (2007) Giant cell tumor of the skull in pediatric patients. Report of two cases. J Neurosurg 107:69–74
Notarianni C, Abreo F, Nanda A (2008) Cranial vault metastasis of giant cell tumor. Ann Diagn Pathol 12:286–289
Matsushige T, Nakaoka M, Yahara K, Kagawa K, Miura H, Ohnuma H, Kurisu K (2008) Giant cell tumor of the temporal bone with intratumoral hemorrhage. J Clin Neurosci 15:923–927
Isaacson B, Berryhill W, Arts HA (2009) Giant-cell tumors of the temporal bone: management strategies. Skull Base 19:291–301
Company MM, Ramos R (2009) Giant cell tumor of the sphenoid. Arch Neurol 66:134–135
Karamanakos PN, Jaaskelainen JE, Alafuzoff I, Pirinen E, Vanninen R, Silvennoinen S, Sankilampi U, Immonen A (2010) Malignant giant cell tumor in the posterior fossa of a neonate. J Neurosurg Pediatr 5:277–282
Roeder F, Timke C, Zwicker F, Thieke C, Bischof M, Debus J, Huber PE (2010) Intensity modulated radiotherapy (IMRT) in benign giant cell tumors–a single institution case series and a short review of the literature. Radiat Oncol 5:18
Mendenhall WM, Zlotecki RA, Scarborough MT, Gibbs CP, Mendenhall NP (2006) Giant cell tumor of bone. Am J Clin Oncol 29:96–99
Wulling M, Engels C, Jesse N, Werner M, Delling G, Kaiser E (2001) The nature of giant cell tumor of bone. J Cancer Res Clin Oncol 127:467–474
Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11:275–280
Acknowledgments
We would like to thank Jose Jasper L. Andal (Department of Pathology and Cell Biology, Columbia University in the City of New York, USA) for assistance with reviewing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Zhenyu Zhang and Jian Xu have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Fig. 1
Age distribution in patients with GCTs of the skull. The majority (63.8 %) of the patients were diagnosed in their 2nd, 3rd and 4th decades of life (TIFF 919 kb)
Supplementary Fig. 2
Survival curves (Kaplan–Meier methods) in GCTs of the skull according to treatment patterns. a Overall survival (OS) was significantly influenced by treatment patterns (p = 0.012). Patients underwent subtotal removal (STR) with RT had the significantly better OS than that of patients underwent STR without RT (Bonferroni correction, p = 0.017). The difference of OS between patients underwent gross total removal (GTR) with or without RT and patients underwent STR with RT did not reach statistical significance (Bonferroni correction, p = 0.416). The difference of OS between patients underwent GTR with or without RT and patients underwent STR without RT did not reach statistical significance (Bonferroni correction, p = 0.041). b Event-free survival (EFS) was significantly influenced by treatment patterns (p < 0.001). Patients underwent GTR with or without RT had the significantly better EFS than that of patients underwent STR without RT (Bonferroni correction, p < 0.001). Patients underwent STR with RT had the significantly better EFS than that of patients underwent STR without RT (Bonferroni correction, p = 0.001). The difference of EFS between patients underwent GTR with or without RT and patients underwent STR with RT did not reach statistical significance (Bonferroni correction, p = 0.097) (TIFF 1869 kb)
Rights and permissions
About this article
Cite this article
Zhang, Z., Xu, J., Yao, Y. et al. Giant cell tumors of the skull: a series of 18 cases and review of the literature. J Neurooncol 115, 437–444 (2013). https://doi.org/10.1007/s11060-013-1242-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-013-1242-z